Invasive infection due to Candida species is a condition associated with medical progress. It
is a common health care–associated infection and is widely recognized as a major cause of …

Candidemia and invasive candidiasis are major causes of morbidity and mortality, and their
incidence is increasing because of the growing complexity of patients. Five species of …

Every year, Candida, Aspergillus, Cryptococcus and Pneumocystis infect an estimated two
million individuals worldwide. Most are immunocompromised or critically ill. Candida is the …

Importance Although frequently used in treating intensive care unit (ICU) patients with
sepsis, empirical antifungal therapy, initiated for suspected fungal infection, has not been …

There has been an overall increase in fungal healthcare–associated infections (HAIs) that is
likely a consequence of the advances in medical and surgical therapies. The wider use of …

Among 1846 fungal clinical isolates from 31 countries, echinocandin resistance in Candida
spp. ranged from 0.0% to 2.8%(highest for anidulafungin versus Candida glabrata), and …

Background Antifungal therapy saves lives, if given early in life-threatening invasive
infection, and also greatly reduces morbidity in hundreds of millions of patients worldwide …

Background: Implementation of an antimicrobial stewardship program is recommended as
one solution to combat increasing antimicrobial resistance. Most antimicrobial stewardship …

Bloodstream infections (BSI) are infectious diseases defined by the presence of viable
bacterial or fungal microorganisms in the bloodstream (later demonstrated by the positivity of …

Intra-abdominal candidiasis (IAC) is poorly understood compared to candidemia. We
described the clinical characteristics, microbiology, treatment and outcomes of IAC, and …